AKBA Q4 2017 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+5588.3% YoY

Gross Profit

$19M21.7% margin

Operating Income

$11M13.0% margin

Net Income

$12M14.1% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+111.5%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$364M

Total Liabilities

$245M

Stockholders' Equity

$119M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$2M	+5588.3%
Gross Profit	$19M	-$32M	+159.4%
Operating Income	$11M	-$38M	+129.9%
Net Income	$12M	-$38M	+132.4%